{"id":"W2599197862","doi":"10.1200/jco.2015.33.15_suppl.tps10081","title":"A phase II study of pazopanib in children, adolescents, and young adults with refractory solid tumors.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Pazopanib; Medicine; Sarcoma; Hepatoblastoma; Rhabdomyosarcoma; Soft tissue sarcoma; Refractory (planetary science); Internal medicine; Oncology; Phases of clinical research; Trabectedin; Response Evaluation Criteria in Solid Tumors; Cancer; Pharmacodynamics; Chemotherapy; Pharmacokinetics; Pathology; Sunitinib","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001335914,0.001362188,0.001716526,0.0003730219,0.0005148474,0.0007269096,0.000657507,0.0008746551,0.004526274],"category_scores_gemma":[0.0007667062,0.0006115824,0.0008502914,0.0005170056,0.000683573,0.0006216256,0.0004377847,0.003352656,0.001166451],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008852147,"about_ca_system_score_gemma":0.002850025,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001970885,"about_ca_topic_score_gemma":0.004385076,"domain_scores_codex":[0.9996316,0.0001452326,0.00002853735,0.0000532028,0.00005750329,0.00008382891],"domain_scores_gemma":[0.9990863,0.00009443869,0.0001413923,0.00004700712,0.00006729029,0.0005636679],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4938602,0.1565748,0.05024356,0.002355958,0.00251823,0.002494716,0.001090865,0.003012734,0.06500174,0.001002581,0.03079391,0.1910508],"study_design_scores_gemma":[0.611771,0.3169205,0.04335254,0.0001085159,0.000683433,0.002222949,0.0002208722,0.0009004821,0.003873081,0.0002954526,0.01961476,0.00003636131],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9766889,0.005283392,0.0008779608,0.001250858,0.0002648042,0.007530003,0.004466073,0.0001191863,0.00351884],"genre_scores_gemma":[0.9536334,0.01024755,0.004536694,0.003013743,0.0003939162,0.01369832,0.009500441,0.00007327766,0.004902654],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004526274,"threshold_uncertainty_score":0.01514196,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08232619701603851,"score_gpt":0.4458397387540232,"score_spread":0.3635135417379847,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}